MT-MMP-1 Double Nickase Plasmid (h): sc-401028-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- MT-MMP-1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- MT-MMP-1 Double Nickase Plasmid (h) and MT-MMP-1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting MMP14. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: MT-MMP-1 Antibody (C-7): sc-377097
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MT-MMP-1 Double Nickase Plasmid (h) | sc-401028-NIC | 20 µg | $410.00 | |||
MT-MMP-1 Double Nickase Plasmid (h2) | sc-401028-NIC-2 | 20 µg | $410.00 |
MMP14 encodes membrane type 1 matrix metalloproteinase (MT-MMP-1), a transmembrane endopeptidase that drives pericellular extracellular matrix remodeling by cleaving collagen and other matrix substrates and by activating pro-MMP2. By localizing proteolysis to the cell surface, MT-MMP-1 coordinates invasive migration, focal adhesion turnover, and tissue morphogenesis through integrin-linked signaling and matrix-derived cueing that intersects with pathways such as TGF-β and hypoxia-responsive programs. Dysregulated MMP14 activity has been linked to altered stromal remodeling, increased cell motility, and angiogenic microenvironment changes observed across fibrotic and malignant contexts. These properties make MMP14 a central node for studying protease-dependent invasion and matrix signaling in human cell models.
MT-MMP-1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the MMP14 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within MMP14. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt MMP14 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of MMP14-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.